Kobe, Japan

Nobuya Kajiwara

This inventor holds 2 USPTO granted patents. Top assignee: International Reagents Corp.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuya Kajiwara. Retrieved from https://idiyas.com/inventor/nobuya-kajiwara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nobuya Kajiwara: Innovator in Specimen Collection Technology

Introduction

Nobuya Kajiwara is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of specimen collection technology. With a total of two patents to his name, Kajiwara's work has had a meaningful impact on medical and research practices.

Latest Patents

Kajiwara's latest patents include an applicator tip for taking specimens and a container for receiving specimens. These innovations are designed to enhance the efficiency and reliability of specimen collection processes.

Career Highlights

Kajiwara is currently employed at International Reagents Corporation, where he continues to develop innovative solutions in his field. His work at the company reflects his commitment to advancing medical technology.

Collaborations

Kajiwara collaborates with talented coworkers, including Hitomi Iori and Koji Ochiai. Their combined expertise fosters a creative environment that drives innovation.

Conclusion

Nobuya Kajiwara is a dedicated inventor whose contributions to specimen collection technology are noteworthy. His patents and collaborative efforts continue to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…